DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+4.03%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$194M
AUM Growth
+$2.85M
(+1.5%)
Cap. Flow
-$7.26M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
44.93%
Holding
90
New
4
Increased
18
Reduced
33
Closed
6
Top Buys
| 1 |
Amazon
AMZN
|
$3.26M |
| 2 |
Micron Technology
MU
|
$1.71M |
| 3 |
Citigroup
C
|
$1.47M |
| 4 |
Sprott Uranium Miners ETF
URNM
|
$1.15M |
| 5 |
Amgen
AMGN
|
$806K |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$2.79M |
| 2 |
Apple
AAPL
|
$2.33M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$1.2M |
| 4 |
Biohaven
BHVN
|
$1.03M |
| 5 |
SPDR Gold Trust
GLD
|
$972K |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.85% |
| 3 | Communication Services | 9.23% |
| 4 | Consumer Discretionary | 8.15% |
| 5 | Financials | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lineage Cell Therapeutics
LCTX
$276M
| $97.5K | 0.04% |
107,751
| – | – |
|
|
TBHC
77
The Brand House Collective, Inc. Common Stock
TBHC
$33M
| $55.7K | 0.02% |
25,415
| – | – |
|
78
Equillium
EQ
$64.7M
| $27.4K | 0.01% |
32,962
| – | – |
|
79
Ovid Therapeutics
OVID
$93.9M
| $17.4K | 0.01% |
14,750
-27,000
| -65% | -$31.9K |
|
80
Biogen
BIIB
$20.2B
| – | – |
-1,000
| Closed | -$232K |
|
81
Esperion Therapeutics
ESPR
$488M
| – | – |
0
| – | – |
|
82
Samsara
IOT
$20.3B
| – | – |
-10,000
| Closed | -$337K |
|
83
Nuveen Floating Rate Income Fund
JFR
$1.13B
| – | – |
-29,500
| Closed | -$255K |
|
84
Johnson & Johnson
JNJ
$429B
| – | – |
-3,000
| Closed | -$438K |
|
85
Shopify
SHOP
$184B
| – | – |
-4,000
| Closed | -$264K |
|
86
Snowflake
SNOW
$72.8B
| – | – |
-3,250
| Closed | -$439K |
|
87
Vanguard S&P 500 ETF
VOO
$726B
| – | – |
0
| – | – |
|